Companies: 49,246 Total Market Cap: 132596284745423.86

Fleury S.A.

BVMF-FLRY3
Healthcare Diagnostics & Research
Rank #8190
Market Cap 1.24 B
Volume 2.30 M
Price 2.26
Change (%) 0.47%
Country or region Brazil Brazil

Fleury S.A.'s latest marketcap:

1.24 B

As of 05/20/2025, Fleury S.A.'s market capitalization has reached $1.24 B. According to our data, Fleury S.A. is the 8190th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap 1.24 B
Revenue (ttm) 1.37 B
Net Income (ttm) 110.50 M
Shares Out 545.02 M
EPS (ttm) 0.20
Forward PE 10.08
Ex-Dividend Date 03/07/2025
Earnings Date 05/08/2025
Market Cap Chart
Data Updated: 05/20/2025

Fleury S.A.'s yearly market capitalization.

Fleury S.A. has seen its market value drop from R$8.58 B to R$7.01 B since 2020, representing a total decrease of 18.20% and an annual compound decline rate (CAGR) of 4.48%.
Date Market Cap Change (%)
05/20/2025 R$7.01 B 4.81%
12/30/2024 R$6.57 B -33.4%
12/28/2023 R$9.86 B 74.25%
12/29/2022 R$5.66 B -0.72%
12/30/2021 R$5.70 B -33.5%
12/30/2020 R$8.58 B

Company Profile

About Fleury S.A.

Fleury S.A., along with its subsidiaries, delivers comprehensive medical services across Brazil, specializing in diagnostics, treatment, clinical analysis, health management, and specialized care in orthopedics and ophthalmology.

Business Segments

  • Diagnostic Medicine: Laboratory and imaging tests, genomics, and diagnostic information services.
  • Integrated Medicine: Health management, check-ups, clinic day services, infusion centers, and specialized orthopedic and ophthalmological care.
  • Dental: Dental imaging tests and diagnostic imaging services.

Digital Healthcare Platform

The company offers Saúde I, a digital platform enabling teleconsultations, in-person appointments, diagnostic test scheduling, electronic medical records, and personalized health management.

Brand Portfolio

Fleury operates under multiple brand names, including Fleury, Felippe Mattoso, Labs a+, Diagnoson a+, Papaiz, Serdil, LAFE, and others, providing services through customer service units and hospital-based facilities.

Company Background

Founded in 1926, Fleury S.A. is headquartered in São Paulo, Brazil, and has established itself as a leader in the country's healthcare sector.

Frequently Asked Questions

As of 05/20/2025, Fleury S.A. (including the parent company, if applicable) has an estimated market capitalization of $1.24 B USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.

Fleury S.A. global market capitalization ranking is approximately 8190 as of 05/20/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.

Stock Detail

Country or region Brazil
Founded 1926
IPO Date n/a
Employees 27,500
CEO Jeane Tsutsui
Sector Healthcare
Industry Diagnostics & Research
Address Avenida Morumbi
São Paulo, 04703-003
Brazil
Website https://ri.fleury.com.br
People Also Watch
TMO
413.75 0.47%
Danaher
197.77 0.47%
Lonza Group AG
679.37 0.47%
IDXX
517.16 0.47%